fluoxetine has been researched along with dmp 696 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, GJ; Gold, LH; Nielsen, DM | 1 |
| Carboni, L; Castelletti, L; Domenici, E; Milli, A; Piubelli, C; Vighini, M | 1 |
2 other study(ies) available for fluoxetine and dmp 696
| Article | Year |
|---|---|
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Topics: Animals; Antidepressive Agents; Clorgyline; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hindlimb Suspension; Male; Mice; Morpholines; Motor Activity; Paroxetine; Pyrazoles; Pyrimidines; Pyrroles; Reboxetine; Receptors, Corticotropin-Releasing Hormone; Selegiline; Swimming; Tranylcypromine; Triazines | 2004 |
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists.
Topics: Animals; Antidepressive Agents; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Fluoxetine; Frontal Lobe; Hippocampus; Male; Neurokinin-1 Receptor Antagonists; Peptide Mapping; Piperidines; Proteomics; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Spectrum Analysis; Tetrazoles; Triazines | 2006 |